These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21911832)

  • 61. Warfarin therapy for an octogenarian who has atrial fibrillation.
    Gage BF; Fihn SD; White RH
    Ann Intern Med; 2001 Mar; 134(6):465-74. PubMed ID: 11255522
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study.
    Launiainen T; Sajantila A; Rasanen I; Vuori E; Ojanperä I
    Eur J Clin Pharmacol; 2010 Jan; 66(1):97-103. PubMed ID: 19779704
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Interaction between warfarin and oral miconazole gel].
    Ogard CG; Vestergaard H
    Ugeskr Laeger; 2000 Oct; 162(41):5511. PubMed ID: 11068529
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Kamel H; Johnston SC; Easton JD; Kim AS
    Stroke; 2012 Mar; 43(3):881-3. PubMed ID: 22308255
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 67. International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.
    Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
    Curr Med Res Opin; 2014 Dec; 30(12):2437-42. PubMed ID: 25170587
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fish oil interaction with warfarin.
    Buckley MS; Goff AD; Knapp WE
    Ann Pharmacother; 2004 Jan; 38(1):50-2. PubMed ID: 14742793
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Medical mystery. A woman with too-thin blood. Why was the patient bleeding? What's her case mean to you?
    Heart Advis; 2004 Dec; 7(12):4-5. PubMed ID: 15779134
    [No Abstract]   [Full Text] [Related]  

  • 70. Rivaroxaban in atrial fibrillation.
    Giorgi MA; Miguel LS
    Vasc Health Risk Manag; 2012; 8():525-31. PubMed ID: 22973107
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
    Naganuma M; Shiga T; Sato K; Murasaki K; Hashiguchi M; Mochizuki M; Hagiwara N
    Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Warfarin--indications, risks and drug interactions.
    Tadros R; Shakib S
    Aust Fam Physician; 2010 Jul; 39(7):476-9. PubMed ID: 20628660
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
    Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J; Delaitre O; Hammès F; de Pouvourville G
    Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Potentiation of the anticoagulant effect of warfarin.
    Fitzmaurice DA; Murray JA
    Postgrad Med J; 1997 Jul; 73(861):439-40. PubMed ID: 9338037
    [No Abstract]   [Full Text] [Related]  

  • 76. Probable interaction between warfarin and bee pollen.
    Hurren KM; Lewis CL
    Am J Health Syst Pharm; 2010 Dec; 67(23):2034-7. PubMed ID: 21098375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Summaries for patients. Rivaroxaban in patients transitioned from vitamin K antagonist therapy.
    Ann Intern Med; 2013 Jun; 158(12):I-28. PubMed ID: 23778921
    [No Abstract]   [Full Text] [Related]  

  • 78. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
    Singer DE; Hellkamp AS; Yuan Z; Lokhnygina Y; Patel MR; Piccini JP; Hankey GJ; Breithardt G; Halperin JL; Becker RC; Hacke W; Nessel CC; Mahaffey KW; Fox KA; Califf RM;
    J Am Heart Assoc; 2015 Mar; 4(3):e001349. PubMed ID: 25736441
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
    Yates SW
    Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Probable warfarin and dapsone interaction.
    Truong T; Haley J
    Clin Appl Thromb Hemost; 2012; 18(1):107-9. PubMed ID: 21890570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.